India.com News Desk | Dec 26, 2021, 2:13 AM IST
It is the second vaccine to receive the regulator's nod for use among those below 18 years after Zydus Cadila's needle-free COVID-19 vaccine ZyCoV-D.
India.com News Desk | Dec 25, 2021, 10:12 PM IST
PM's announcement came soon after the Drugs Controller General of India (DCGI) granted emergency use authorisation to Bharat Biotech's Covaxin for children above 12 years with certain conditions on Saturday.
India.com News Desk | Dec 20, 2021, 5:51 PM IST
The development comes as India has detected over 160 new cases of the emergent Omicron variant of the coronavirus.
India.com News Desk | Dec 9, 2021, 10:30 PM IST
The FDA authorized booster shots of the COVID-19 vaccine from Pfizer and BioNTech to those aged 16 and 17
India.com News Desk | Dec 6, 2021, 4:44 PM IST
Passengers in possession of final COVID vaccination certificate (two doses complete) shall be exempted from on arrival testing procedures.
India.com News Desk | Dec 1, 2021, 9:30 PM IST
Recently, Kerala, Rajasthan, Karnataka and Chhattisgarh have urged the Centre to decide on allowing booster doses of Covid-19 vaccine diseased amid concerns raised by 'Omicron', the new variant of SARS-CoV-2.
India.com News Desk | Nov 30, 2021, 5:12 PM IST
This comes after Moderna CEO Stephane Bancel warned that the existing Covid-19 vaccines would be less effective against the Omicron variant than they have been against the Delta variant.
India.com News Desk | Nov 17, 2021, 11:25 PM IST
Earlier in the day Union Health Minister Mansukh Mandaviya also appealed to all eligible citizens to get vaccinated. The cumulative coronavirus vaccines administered in India has exceeded 113.68 crore mark.
India.com News Desk | Nov 17, 2021, 5:33 PM IST
It must be noted that Covishield and Covaxin, which received emergency use listing (EUL) from the World Health Organisation, have so far been recognised by 96 countries.
India.com News Desk | Nov 12, 2021, 8:24 AM IST
More than 12 crore doses of Covaxin have been administered so far since the beginning of the vaccination campaign in January.
India.com News Desk | Nov 10, 2021, 10:04 PM IST
Bharat Biotech is also looking at nasal vaccine as a booster dose as its scaling up capacity is very easy when compared with Covaxin, company Chairman and Managing Director Krishna Ella said.
India.com News Desk | Nov 8, 2021, 4:48 PM IST
If the vaccine gets approval from the Drugs Controller General of India (DCGI), it will be the second Covid-19 vaccine after Zydus Cadila's needle-free ZyCoV-D to receive EUA for use in those below 18 years.
English
